PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för visnagin. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

17 hits

Bibliografisk träff 2016-12-12

Khellin and Visnagin, Furanochromones from Ammi visnaga (L.) Lam., as Potential Bioherbicides.

Travaini ML, Sosa GM, Ceccarelli EA, Walter H, Cantrell CL, Carrillo NJ, Dayan FE, Meepagala KM, Duke SO.

J Agric Food Chem · journal article · DOI 10.1021/acs.jafc.6b02462

Bibliografisk träff 2016-02-01

Visnagin-a new protectant against doxorubicin cardiotoxicity? Inhibition of mitochondrial malate dehydrogenase 2 (MDH2) and beyond.

Xi L.

Ann Transl Med · editorial; journal article · DOI 10.3978/j.issn.2305-5839.2015.10.43

Bibliografisk träff 2014-12-01

Visnagin protects against doxorubicin-induced cardiomyopathy through modulation of mitochondrial malate dehydrogenase.

Liu Y, Asnani A, Zou L, Bentley VL, Yu M, Wang Y, Dellaire G, Sarkar KS, Dai M, Chen HH, Sosnovik DE, Shin JT, Haber DA, Berman JN, Chao W, Peterson RT.

Sci Transl Med · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1126/scitranslmed.3010189

Bibliografisk träff 2014-08-11

Validated HPLC method for simultaneous estimation of khellol glucoside, khellin and visnagin in Ammi visnaga L. fruits and pharmaceutical preparations.

Badr JM, Hadad GM, Nahriry K, Hassanean HA.

Nat Prod Res · validation study; journal article · DOI 10.1080/14786419.2014.945170

Bibliografisk träff 2013-09-19

Khellin and visnagin differentially modulate AHR signaling and downstream CYP1A activity in human liver cells.

Vrzal R, Frauenstein K, Proksch P, Abel J, Dvorak Z, Haarmann-Stemmann T.

PLoS One · research support, non-u.s. gov't; research-article; journal article · DOI 10.1371/journal.pone.0074917

Bibliografisk träff 2012-10-24

Pharmacokinetic evaluation of visnagin and Ammi visnaga aqueous extract after oral administration in rats.

Haug KG, Weber B, Hochhaus G, Butterweck V.

Planta Med · journal article · DOI 10.1055/s-0032-1315393

Bibliografisk träff 2011-11-09

Nonlinear pharmacokinetics of visnagin in rats after intravenous bolus administration.

Haug KG, Weber B, Hochhaus G, Butterweck V.

Eur J Pharm Sci · validation study; journal article · DOI 10.1016/j.ejps.2011.10.023

Bibliografisk träff 2010-11-30

Anti-inflammatory effect of visnagin in lipopolysaccharide-stimulated BV-2 microglial cells.

Lee JK, Jung JS, Park SH, Park SH, Sim YB, Kim SM, Ha TS, Suh HW.

Arch Pharm Res · research support, non-u.s. gov't; journal article · DOI 10.1007/s12272-010-1117-1

Bibliografisk träff 2010-11-11

Prevention of renal crystal deposition by an extract of Ammi visnaga L. and its constituents khellin and visnagin in hyperoxaluric rats.

Vanachayangkul P, Chow N, Khan SR, Butterweck V.

Urol Res · research-article; journal article · DOI 10.1007/s00240-010-0333-y

Bibliografisk träff 2010-10-31

Neuroprotective Effect of Visnagin on Kainic Acid-induced Neuronal Cell Death in the Mice Hippocampus.

Kwon MS, Lee JK, Park SH, Sim YB, Jung JS, Won MH, Kim SM, Suh HW.

Korean J Physiol Pharmacol · research-article; journal article · DOI 10.4196/kjpp.2010.14.5.257

Bibliografisk träff 2009-12-29

An aqueous extract of Ammi visnaga fruits and its constituents khellin and visnagin prevent cell damage caused by oxalate in renal epithelial cells.

Vanachayangkul P, Byer K, Khan S, Butterweck V.

Phytomedicine · research-article; journal article · DOI 10.1016/j.phymed.2009.10.011

Bibliografisk träff 2009-01-21

Determination of visnagin in rat plasma by liquid chromatography with tandem mass spectrometry and its application to in vivo pharmacokinetic studies.

Vanachayangkul P, Butterweck V, Frye RF.

J Chromatogr B Analyt Technol Biomed Life Sci · evaluation study; journal article · DOI 10.1016/j.jchromb.2009.01.014

Bibliografisk träff 2000-02-01

Cardiovascular effects of visnagin on rats.

Duarte J, Torres AI, Zarzuelo A.

Planta Med · research support, non-u.s. gov't; journal article · DOI 10.1055/s-2000-11108

Bibliografisk träff 1999-01-01

Effects of visnagin on cyclic nucleotide phosphodiesterases and their role in its inhibitory effects on vascular smooth muscle contraction.

Duarte J, Lugnier C, Torres AI, Pérez-Vizcaino F, Zarzuelo A, Tamargo J.

Gen Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/s0306-3623(98)00083-4

Bibliografisk träff 1998-02-01

Photophysical properties and photobiological activity of the furanochromones visnagin and khellin.

Borges ML, Latterini L, Elisei F, Silva PF, Borges R, Becker RS, Maçanita AL.

Photochem Photobiol · research support, non-u.s. gov't; journal article · DOI 10.1562/0031-8655(1998)067<0184:ppapao>2.3.co;2

Bibliografisk träff 1997-05-01

Studies on the photobiological activity of two naturally occurring furochromones, visnagin and khellin, in Chlamydomonas reinhardtii.

Schimmer O.

Mutagenesis · comparative study; journal article · DOI 10.1093/mutage/12.3.141

Bibliografisk träff 1995-11-01

Vasodilator effects of visnagin in isolated rat vascular smooth muscle.

Duarte J, Pérez-Vizcaíno F, Torres AI, Zarzuelo A, Jiménez J, Tamargo J.

Eur J Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/0014-2999(95)00418-k